NCT05003479 Clinical Trial of SARS-CoV-2 Vaccine (Vero Cells), Inactivated in Healthy Population Aged 3 to 17 Years(COVID-19) Status UNKNOWN Phase PHASE1
NCT05003466 Study of Inactivated SARS-CoV-2 Vaccine (Vero Cells) in Healthy Population Aged 3 to 17 Years(COVID-19) Status UNKNOWN Phase PHASE2
NCT04998214 Hepatic Manifestations and Effect of Long COVID-19 on Patients With Chronic Liver Disease Status UNKNOWN Phase N/A
NCT04993365 Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell) Status COMPLETED Phase PHASE4
NCT04992273 COVID-19 Administration of Single-Dose Subcutaneous Anti- Spike(s) SARS-CoV-2 Monoclonal Antibodies Casirivimab and Imdevimab in High-Risk Pediatric Participants Under 12 Years of Age Status TERMINATED Phase PHASE2
NCT04992260 Efficacy, Immunogenicity and Safety of COVID-19 Vaccine , Inactivated in Children and Adolescents Status COMPLETED Phase PHASE3
NCT04992208 Safety of an Inactivated SARS-CoV-2 Vaccine for Prevention of COVID-19 in Children and Adolescents Status COMPLETED Phase PHASE4
NCT04990544 Phase II Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 Status UNKNOWN Phase PHASE2
NCT04990466 Phase 2b/3 Trial of VSV-ΔG SARS-CoV-2 Vaccine (BRILIFE) Against Approved Comparator Vaccine. Status WITHDRAWN Phase PHASE2/PHASE3
NCT04988269 Assessment of Diurnal Salivary Cortisol Production in COVID-19 Status COMPLETED Phase N/A
NCT04988035 ACTIV-5 / Big Effect Trial (BET-C) for the Treatment of COVID-19 Status COMPLETED Phase PHASE2
NCT04982068 Phase I Clinical Trial of Recombinant SARS-CoV-2 Spike Protein Vaccine (CHO Cell) for the Prevention of COVID-19 Status UNKNOWN Phase PHASE1
NCT04981249 Chronic Multimorbidity Patterns in Relation to COVID-19 Severe Infection Status COMPLETED Phase N/A
NCT04978571 Percutaneous Electrical Nerve Field Stimulation (PENFS) in Patients With Post Concussion Syndrome (PCS) Status RECRUITING Phase NA
NCT04974164 Effectiveness of COVID-19 Vaccine for Prevention of COVID-19 in the Dominican Republic Status COMPLETED Phase N/A
NCT04973449 Phase II/III Study of AZD2816, for the Prevention of COVID-19 in Adults Status COMPLETED Phase PHASE2/PHASE3
NCT04967742 A Extension Study to Evaluate the Safety, Tolerability, and Immunogenicity of UB-612 COVID-19 Vaccine Status COMPLETED Phase PHASE1